サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1737309

経口固形製剤の世界市場

Oral Solid Dosage Pharmaceutical Formulation

出版日
ページ情報
英文 285 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.87円
経口固形製剤の世界市場
出版日: 2025年05月30日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 285 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

経口固形製剤の世界市場は2030年までに8億1,860万米ドルに達する見込み

2024年に6億6,800万米ドルと推定される経口固形製剤の世界市場は、2024年から2030年にかけてCAGR 3.4%で成長し、2030年には8億1,860万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである錠剤は、CAGR 2.9%を記録し、分析期間終了時には2億8,010万米ドルに達すると予測されます。カプセル剤セグメントの成長率は、分析期間中CAGR 4.6%と推定されます。

米国市場は1億8,200万米ドルと推定、中国はCAGR 6.3％で成長すると予測

米国の経口固形製剤市場は、2024年に1億8,200万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを6.3%として、2030年までに1億6,180万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.4%と2.6%と予測されています。欧州では、ドイツがCAGR 2.0%で成長すると予測されています。

世界の経口固形製剤市場- 主要動向と促進要因まとめ

なぜ経口固形製剤はドラッグデリバリーの要であり続けるのか？

経口固形製剤（OSD）の形態は、主に錠剤、カプセル剤、粉末剤であるが、投与の容易さ、費用対効果、患者のコンプライアンスの高さ、製造の拡張性などの理由から、世界の医薬品製剤の主流を占め続けています。生物製剤や非経口剤への関心が高まっているにもかかわらず、OSDは世界の医薬品処方の50％以上を占めています。その安定性、放出制御の可能性、および長い保存期間により、OSDは特に低・中所得市場における慢性療法レジメンや大規模流通に有利です。

OSDフォーマットの汎用性は、循環器系、抗感染症、中枢神経系、腫瘍、消化器系などの幅広い治療カテゴリーをサポートしています。慢性疾患の蔓延、高齢者人口の増加、個別化医療への需要は、OSDの重要性をさらに高めています。口腔内崩壊錠（ODT）、乱用抑止製剤、多粒子カプセルなどの最近の技術革新は、小児や高齢者の服薬アドヒアランス、用量漸増、バイオアベイラビリティに関する課題に対処しており、OSDが世界なドラッグデリバリーシステムの基盤であり続けることを確実にしています。

製剤科学と製造技術はOSD開発の効率をどのように高めているのでしょうか？

製剤技術の進歩により、経口固形製剤の性能、安定性、放出プロファイルは大幅に改善されています。ホットメルト押出、噴霧乾燥、およびナノミリングにより、難溶性原薬（API）のOSD開発が可能になり、増加する生物薬剤学分類システム（BCS）クラスIIおよびIVの薬剤ポートフォリオに対応しています。徐放性、遅延放出性、および拍動性システムを含む改良放出技術は、治療域を改善し、投与回数を減らすために導入されています。

製造業者は、生産効率の向上、サイクルタイムの短縮、一貫した品質の確保を目的として、連続製造、プロセス分析技術（PAT）、Quality by Design（QbD）の原則を採用するようになってきています。錠剤の自動圧縮、リアルタイムのモニタリング、高度な造粒方法により、バッチ間の再現性が向上し、材料の無駄が削減されています。さらに、3Dプリンティングは、患者ごとの投与量のカスタマイズや多剤併用療法のために研究されています。これらの技術革新は、製剤の柔軟性を拡大するだけでなく、規制当局の承認を合理化し、市場投入までの時間を短縮しています。

OSD製剤の需要を牽引している治療領域と地域市場は？

OSDは広範な治療分野で使用されていますが、特に慢性疾患管理においてその優位性が顕著です。高血圧、糖尿病、うつ病、てんかん、感染症は、世界的にOSD生産量の上位を占めています。また、がん領域や自己免疫疾患領域では、経口標的治療薬やキナーゼ阻害剤の固形製剤の利用が増加しており、外来治療プロトコルが改善されています。

北米と欧州は、先進的な製造施設、規制に関する専門知識、高い処方薬使用率に支えられ、依然として主要市場です。インドと中国を中心とするアジア太平洋地域は、医療アクセスの向上、国内製薬産業の拡大、強力な輸出インフラにより、OSDの生産量が最も急速に伸びています。ラテンアメリカ、中東・アフリカでは、公衆衛生への取り組み、ジェネリック医薬品の普及、国内製造能力の向上により、採用が拡大しています。これらの地域は、特に錠剤やカプセルの形態の必須医薬品において、数量拡大の可能性が高い地域です。

OSD製剤市場の長期的成長と戦略的革新の原動力は？

経口固形製剤市場の成長の原動力は、費用対効果の高い治療、ジェネリック医薬品の代替、慢性疾患における長期的な治療アドヒアランスに対する需要の高まりです。支払者や政府は手頃な価格のヘルスケアソリューションを求めており、OSDは依然としてフォーミュラリーへの組み入れや償還に適したフォーマットとなっています。また、特許満了に伴い、ジェネリックおよびブランドジェネリックのOSD製品には、世界市場において大きなビジネスチャンスが生まれています。

戦略的イノベーションは、合剤（FDC）、味覚マスク小児用製剤、患者中心の包装に焦点が当てられています。各社は、嚥下、安定性、薬物放出動態を改善するために、多層錠、多粒子デリバリーシステム、フィルムコーティング製剤を開発しています。持続可能性は優先事項として浮上しており、生分解性包装やより環境に優しい合成法が人気を集めています。ファーマコゲノミクスと個別化投薬が進化するにつれ、OSDはモジュール式投薬プラットフォームとデジタル統合によって適応し、世界の医薬品業界における継続的な優位性を確保すると予想されます。

セグメント

剤形（錠剤、カプセル剤、粉末剤、ロゼンジ＆パスティル、グミ）、流通チャネル（病院薬局流通チャネル、小売薬局流通チャネル、オンライン薬局流通チャネル）

調査対象企業の例（全42件）

  • AbbVie Inc.
  • Aenova Group
  • Alcami Corporation
  • Almac Group
  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Catalent Inc.
  • CordenPharma International
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Lonza Group AG
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP34145

Global Oral Solid Dosage Pharmaceutical Formulation Market to Reach US$818.6 Million by 2030

The global market for Oral Solid Dosage Pharmaceutical Formulation estimated at US$668.0 Million in the year 2024, is expected to reach US$818.6 Million by 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. Tablets Form, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$280.1 Million by the end of the analysis period. Growth in the Capsules Form segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$182.0 Million While China is Forecast to Grow at 6.3% CAGR

The Oral Solid Dosage Pharmaceutical Formulation market in the U.S. is estimated at US$182.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$161.8 Million by the year 2030 trailing a CAGR of 6.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Oral Solid Dosage Pharmaceutical Formulation Market - Key Trends & Drivers Summarized

Why Do Oral Solid Dosage Forms Remain the Cornerstone of Pharmaceutical Drug Delivery Systems?

Oral Solid Dosage (OSD) forms-primarily tablets, capsules, and powders-continue to dominate global pharmaceutical formulations due to their ease of administration, cost-effectiveness, high patient compliance, and manufacturing scalability. Despite growing interest in biologics and parenterals, OSDs account for over 50% of global pharmaceutical prescriptions. Their stability, controlled-release potential, and long shelf life make them especially advantageous for chronic therapy regimens and large-scale distribution, particularly in low- and middle-income markets.

The versatility of OSD formats supports an expansive range of therapeutic categories including cardiovascular, anti-infective, CNS, oncology, and gastrointestinal treatments. The rise in chronic disease prevalence, geriatric population, and demand for personalized medicine further reinforces the relevance of OSDs. Recent innovations-such as orally disintegrating tablets (ODTs), abuse-deterrent formulations, and multi-particulate capsules-are addressing challenges related to pediatric and geriatric adherence, dosage titration, and bioavailability, ensuring that OSDs remain the foundation of global drug delivery systems.

How Are Formulation Science and Manufacturing Technologies Enhancing the Efficiency of OSD Development?

Advancements in formulation technologies have significantly improved the performance, stability, and release profiles of oral solid dosage drugs. Hot melt extrusion, spray drying, and nano-milling are enabling the development of OSDs for poorly soluble Active Pharmaceutical Ingredients (APIs), addressing the growing Biopharmaceutics Classification System (BCS) class II and IV drug portfolios. Modified-release technologies, including extended-release, delayed-release, and pulsatile systems, are being deployed to improve therapeutic windows and reduce dosing frequency.

Manufacturers are increasingly adopting continuous manufacturing, Process Analytical Technology (PAT), and Quality by Design (QbD) principles to enhance production efficiency, reduce cycle times, and ensure consistent quality. Automated tablet compression, real-time monitoring, and advanced granulation methods are improving batch-to-batch reproducibility and reducing material wastage. Moreover, 3D printing is being explored for patient-specific dosage customization and multi-drug combinations. These innovations are not only expanding formulation flexibility but also streamlining regulatory approvals and accelerating time-to-market.

Which Therapeutic Areas and Regional Markets Are Driving Demand for OSD Pharmaceutical Formulations?

OSDs are extensively used across a wide array of therapeutic segments, but their dominance is particularly pronounced in chronic disease management. Hypertension, diabetes, depression, epilepsy, and infectious diseases are among the top drivers of volume-based OSD production globally. Oncology and autoimmune segments are also increasingly utilizing oral targeted therapies and kinase inhibitors in solid dosage formats, improving outpatient treatment protocols.

North America and Europe remain the leading markets, supported by advanced manufacturing facilities, regulatory expertise, and high prescription drug usage. The Asia-Pacific region, led by India and China, is experiencing the fastest growth in OSD production due to rising healthcare access, domestic pharmaceutical industry expansion, and strong export infrastructure. Latin America, the Middle East, and Africa are seeing growing adoption through public health initiatives, generics penetration, and increased domestic manufacturing capacity. These regions represent high potential for volume growth, especially for essential medicines in tablet or capsule form.

What Is Powering Long-Term Growth and Strategic Innovation in the OSD Formulations Market?

The growth in the oral solid dosage pharmaceutical formulation market is driven by increasing demand for cost-effective therapies, generics substitution, and long-term treatment adherence in chronic conditions. With payers and governments pushing for affordable healthcare solutions, OSDs remain the preferred format for formulary inclusion and reimbursement. Patent expiries are also creating robust opportunities for generic and branded-generic OSD products across global markets.

Strategic innovation is focused on fixed-dose combinations (FDCs), taste-masked pediatric formulations, and patient-centric packaging. Companies are developing multi-layer tablets, multiparticulate delivery systems, and film-coated formats to enhance swallowing, stability, and drug release dynamics. Sustainability is emerging as a priority, with biodegradable packaging and greener synthesis methods gaining traction. As pharmacogenomics and individualized dosing evolve, OSDs are expected to adapt through modular dosing platforms and digital integration, ensuring their continued dominance in the global pharmaceutical landscape.

SCOPE OF STUDY:

The report analyzes the Oral Solid Dosage Pharmaceutical Formulation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Dosage Form (Tablets, Capsules, Powders, Lozenges & Pastilles, Gummies); Distribution Channel (Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • AbbVie Inc.
  • Aenova Group
  • Alcami Corporation
  • Almac Group
  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Catalent Inc.
  • CordenPharma International
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Lonza Group AG
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Oral Solid Dosage Pharmaceutical Formulation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Preference for Patient-Friendly Oral Delivery Formats Propels Demand for Solid Dosage Innovation
    • Expansion of Modified-Release and Targeted Formulations Strengthens Business Case for OSD Technologies
    • Increased Focus on Pediatric and Geriatric Palatability Throws the Spotlight on Taste-Masking Solutions
    • Surge in Fixed-Dose Combination Therapies Accelerates Development of Multi-API Solid Dosage Forms
    • Availability of 3D Printing Technologies in OSD Design Enhances Customization and Precision Dosing
    • Growth in High-Potency APIs Spurs Demand for Specialized Containment and Tableting Techniques
    • Regulatory Support for Continuous Manufacturing Processes Drives Operational Efficiency in OSD Production
    • Integration of AI in Formulation Development Enables Predictive Modeling and Faster Time-to-Market
    • Rising Demand for Stability-Enhanced OSD Products Strengthens Need for Novel Excipients
    • Expansion of Contract Manufacturing and Formulation Outsourcing Supports Flexible Capacity Scaling
    • Growing Emphasis on Bioavailability Improvement Enhances Solubility-Enhancing OSD Innovations
    • Development of Abuse-Deterrent Formulations Sustains Growth in Controlled Substance Applications
    • Challenges in Moisture and Oxygen Sensitivity Drive Demand for Barrier Film-Coated Tablets
    • Increased Regulatory Scrutiny on Nitrosamine Contamination Spurs Reformulation Initiatives
    • Adoption of Continuous Granulation and Tableting Enhances Quality Assurance in OSD Lines
    • Rising Demand for Vegan and Gelatin-Free Capsules Expands OSD Opportunities in Plant-Based Markets
    • Growth in Specialty Generics and Complex Oral Drugs Spurs Need for Advanced Formulation Strategies
    • Increasing Market Entry of Nutraceuticals in OSD Format Expands Over-The-Counter Portfolio Range
    • Standardization of Global Pharmacopeial Guidelines Enhances International Formulation Consistency
    • Expansion of Real-Time Release Testing (RTRT) in OSD Manufacturing Supports Agile Compliance
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Oral Solid Dosage Pharmaceutical Formulation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Tablets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Tablets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Tablets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Powders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Powders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Powders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Lozenges & Pastilles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Lozenges & Pastilles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Lozenges & Pastilles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Gummies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Gummies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Gummies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospital Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Retail Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Online Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Online Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Online Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Oral Solid Dosage Pharmaceutical Formulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • JAPAN
    • Oral Solid Dosage Pharmaceutical Formulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • CHINA
    • Oral Solid Dosage Pharmaceutical Formulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • EUROPE
    • Oral Solid Dosage Pharmaceutical Formulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • FRANCE
    • Oral Solid Dosage Pharmaceutical Formulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • GERMANY
    • Oral Solid Dosage Pharmaceutical Formulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Oral Solid Dosage Pharmaceutical Formulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Oral Solid Dosage Pharmaceutical Formulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Oral Solid Dosage Pharmaceutical Formulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • INDIA
    • Oral Solid Dosage Pharmaceutical Formulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Oral Solid Dosage Pharmaceutical Formulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Oral Solid Dosage Pharmaceutical Formulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • AFRICA
    • Oral Solid Dosage Pharmaceutical Formulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Dosage Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Powders, Lozenges & Pastilles and Gummies for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Oral Solid Dosage Pharmaceutical Formulation by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030

IV. COMPETITION